Usana Health Sciences
USNA
142 hedge funds and large institutions have $567M invested in Usana Health Sciences in 2016 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 40 increasing their positions, 55 reducing their positions, and 14 closing their positions.
57% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 14
4% more funds holding
Funds holding: 136 → 142 (+6)
3.71% less ownership
Funds ownership: 88.75% → 85.04% (-3.7%)
11% less capital invested
Capital invested by funds: $636M → $567M (-$68.4M)
27% less repeat investments, than reductions
Existing positions increased: 40 | Existing positions reduced: 55
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$6.96M |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$5.92M |
| 3 |
D.E. Shaw & Co
New York
|
+$5.21M |
| 4 |
JIM
Jupiter Investment Management
London,
United Kingdom
|
+$4.53M |
| 5 |
Two Sigma Investments
New York
|
+$4.43M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$14.7M |
| 2 |
NAP
New Amsterdam Partners
New York
|
-$13.4M |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
-$13.1M |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
-$3.65M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$3.64M |
USNA Hedge Fund Activity: Q2 2016 in Review
142 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Usana Health Sciences (USNA) for Q2 2016, worth a combined $567M — down 11% from $636M a quarter earlier.
Buyers outnumbered sellers: 22 funds opened new USNA positions and 14 closed out — a net gain of 8 holders — while 40 added to existing stakes and 55 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $6.96M. The largest seller was Vanguard Group, cutting an estimated $14.7M.
- 142 institutional investors held Usana Health Sciences (USNA) as of Q2 2016, up from 136 in Q1 2016.
- Funds reported $567M of Usana Health Sciences stock for Q2 2016, down 11% quarter-over-quarter.
- 22 funds opened new Usana Health Sciences positions in Q2 2016 and 14 closed out, a net change of +8 holders.
- The largest Usana Health Sciences buyer in Q2 2016 was Renaissance Technologies, an estimated $6.96M added.
- The largest Usana Health Sciences seller in Q2 2016 was Vanguard Group, an estimated $14.7M sold.
Based on aggregated 13F filings for Q2 2016.